Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quintuple Therapy for Prevention of Metachronous Liver Metastasis in CRC
NCT05720559Phase 2Not yet recruiting
- Sponsor
- Liaoning Medical Center
- Start
- Mar 2023
- Primary completion
- Mar 2026
- Modality
- Monoclonal Antibodies, Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 2 trial of KL-140, metronidazole, vitamin a, folic acid, tegafur in colorectal cancer (CRC), sponsored by Liaoning Medical Center. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
KL-140metronidazolevitamin afolic acidtegafur
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05720559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05720559.